Read + Share
Becker PS. Allogeneic transplantation provides added benefit to FMS-like tyrosine kinase 3
(FLT3) inhibitors for both low-intensity and high-intensity regimens in
FLT3-mutated acute myeloid leukemia. Cancer 2025;131:e35973.
PMID: 40652363
|
 |
|
